Pannu S, Exline M, Bednash J, Englert J, Diaz P, Bartlett A
Trials. 2024; 25(1):328.
PMID: 38760804
PMC: 11102211.
DOI: 10.1186/s13063-024-08155-0.
Secades J, Gareri P
Rev Neurol. 2022; 75(s05):S1-S89.
PMID: 36544369
PMC: 10548480.
DOI: 10.33588/rn.75s05.2022311.
Young A, Rosas L, Cooper E, Yaxley P, Davis I
J Vet Intern Med. 2022; 36(3):1089-1099.
PMID: 35484990
PMC: 9151482.
DOI: 10.1111/jvim.16434.
Gudi V, Schafer N, Gingele S, Stangel M, Skripuletz T
Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832936
PMC: 8623145.
DOI: 10.3390/ph14111156.
Oddone F, Rossetti L, Parravano M, Sbardella D, Coletta M, Ziccardi L
Pharmaceuticals (Basel). 2021; 14(3).
PMID: 33804675
PMC: 8003774.
DOI: 10.3390/ph14030281.
Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma.
Gandolfi S, Marchini G, Caporossi A, Scuderi G, Tomasso L, Brunoro A
Nutrients. 2020; 12(3).
PMID: 32197303
PMC: 7146438.
DOI: 10.3390/nu12030793.
Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study.
Parisi V, Barbano L, Di Renzo A, Coppola G, Ziccardi L
PLoS One. 2019; 14(7):e0220435.
PMID: 31348806
PMC: 6660126.
DOI: 10.1371/journal.pone.0220435.
Functional rescue in a mouse model of congenital muscular dystrophy with megaconial myopathy.
Sayed-Zahid A, Sher R, Sukoff Rizzo S, Anderson L, Patenaude K, Cox G
Hum Mol Genet. 2019; 28(16):2635-2647.
PMID: 31216357
PMC: 6687948.
DOI: 10.1093/hmg/ddz068.
Neuroprotective agents in the management of glaucoma.
Nucci C, Martucci A, Giannini C, Morrone L, Bagetta G, Mancino R
Eye (Lond). 2018; 32(5):938-945.
PMID: 29472700
PMC: 5944652.
DOI: 10.1038/s41433-018-0050-2.
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function.
Parisi V, Oddone F, Ziccardi L, Roberti G, Coppola G, Manni G
Curr Neuropharmacol. 2017; 16(7):919-932.
PMID: 28676014
PMC: 6120106.
DOI: 10.2174/1570159X15666170703111729.
Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke.
Liu H, Jablonska A, Li Y, Cao S, Liu D, Chen H
Theranostics. 2016; 6(10):1588-600.
PMID: 27446492
PMC: 4955057.
DOI: 10.7150/thno.15492.
Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives.
Roberti G, Tanga L, Michelessi M, Quaranta L, Parisi V, Manni G
Int J Mol Sci. 2015; 16(12):28401-17.
PMID: 26633368
PMC: 4691046.
DOI: 10.3390/ijms161226099.
Effect of oral CDP-choline on visual function in young amblyopic patients.
Fresina M, Dickmann A, Salerni A, De Gregorio F, Campos E
Graefes Arch Clin Exp Ophthalmol. 2007; 246(1):143-50.
PMID: 17638004
DOI: 10.1007/s00417-007-0621-6.
CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke.
Adibhatla R, Hatcher J, Tureyen K
Brain Res. 2005; 1058(1-2):193-7.
PMID: 16153613
PMC: 1939829.
DOI: 10.1016/j.brainres.2005.07.067.
Enhanced therapeutic effect of cytidine-5'-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia model.
Fresta M, WEHRLI E, Puglisi G
Pharm Res. 1995; 12(11):1769-74.
PMID: 8592684
DOI: 10.1023/a:1016234226404.